---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-254959"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2022-09-30T23:59:59+00:00"
generated_at: "2026-06-23T06:26:48.311760+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avita Medical terminates CEO Michael Perry, appoints James Corbett as President and CEO

## Summary
- Dr. Michael Perry terminated as President and CEO effective Sept 28, 2022; he remains a director.
- James Corbett appointed President and CEO; previously a non-executive director since July 2021.
- Corbett receives $600,000 annual base salary, $1M stock option grant (4-year vest), target bonus 60%.
- Corbett has ~40 years med device experience, CEO of Microtherapeutics, ev3, Alphatec Spine.
- Initial employment term of 3 years with automatic one-year renewals; Corbett also joins Board as executive.

## SEC filing metadata
- accession: 0001193125-22-254959
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2022-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/0001193125-22-254959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/d406535d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-254959
- JSON: https://secwatch.observer/filing/0001193125-22-254959.json
- Plain text: https://secwatch.observer/filing/0001193125-22-254959.txt

## Key facts
- Executive change
  James Corbett was appointed as President and CEO at AVITA Medical, Inc..
  - Action: appointed
  - Role: President and CEO
  source text: Effective September 28, 2022, the Board of Directors of the Company appointed James Corbett as the Company’s President and CEO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/0001193125-22-254959-index.htm
- Executive change
  Michael Perry was terminated as President and CEO at AVITA Medical, Inc..
  - Action: terminated
  - Role: President and CEO
  source text: Effective September 28, 2022, the Board of Directors of Avita Medical, Inc. (the “Company”) terminated the employment of Dr. Michael Perry, the Company’s President and CEO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/0001193125-22-254959-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.